Publications Office of the EU
Affaire T-175/22: Recours introduit le 4 avril 2022 — Novartis/EUIPO — AstraZeneca (BREZTRI)
DisplayCustomHeader
Visualizzazione Contenuto Web
Publication Detail Actions Portlet
custom-survey-notification
Publication Detail Portlet

Publication detail

Home
Publication Viewer

Visualizzatore di documenti

Pop up window annotations